Skip to content

A Study on the Therapeutic Effect of Yinshao Decoction in Treating Pediatric Adenoid Hypertrophy with Phlegm Coagulation and Blood Stasis Syndrome

A Study on the Therapeutic Effect of Yinshao Decoction in Treating Pediatric Adenoid Hypertrophy with Phlegm Coagulation and Blood Stasis Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083593
Enrollment
Unknown
Registered
2024-04-29
Start date
2024-04-27
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Adenoid Hypertrophy

Interventions

Experimental group:Yinshao Decoction (in granule form)
Control group:Tongqiao Biyan Granule

Sponsors

Yueyang Hospital of Chinese Integrative Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 10 Years

Inclusion criteria

Inclusion criteria: ? Meets the diagnostic criterion of traditional Chinese and Western medicine for adenoid hypertrophy; ? Without using hormone therapy in the last 3 months before enrollment; ? Age = 4 years and = 10 years old, no gender limitation; ? Understand and agree to participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: ? Patients with congenital maxillofacial malformation or abnormal nasal anatomy; ? Children with severe adenoid hypertrophy, A/N>0.80; ? Those who have other severe diseases, such as cardiovascular and cerebrovascular diseases, genetic metabolic diseases, liver diseases, etc., that may have adverse effects on the results of this study and the patient themselves; ? Individuals who have participated or are currently participating in other clinical studies within 1 month before enrollment; ? Allergic constitution and individuals who are allergic to the prescription herbal medica used in this study.

Design outcomes

Primary

MeasureTime frame
TCM Syndrome Integral;

Secondary

MeasureTime frame
A/N value of adenoid;Eosinophil count and percentage of eosinophils;Portable sleep monitoring;

Countries

China

Contacts

Public ContactJian Shen

Yueyang Hospital of Chinese Integrative Medicine, Shanghai University of Traditional Chinese Medicine

shenj_78@126.com+86 139 1742 2249

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026